Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-03-06 @ 1:24 PM
Study NCT ID:
NCT03479268
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-26
First Post:
2018-03-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-05
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-14
First Submit QC Date:
None
Study First Post Date:
2018-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED